tirzepatide medications FDA approves new version of diabetes drug Mounjaro to be sold for weight loss NICE recommends Lilly's tirzepatide for
Description
The medication is initiated at a lower dose and gradually titrated upward to minimize gastrointestinal side effects and optimize therapeutic response
Research Findings Tirzepatide's clinical development program is among the most comprehensive for any metabolic medication, with the SURPASS trial program establishing efficacy in type 2 diabetes and the SURMOUNT program demonstrating weight management benefits
Sends signals to the brain to curb hunger and caloric intake
Look for board certification in obesity medicine or family medicine with weight management training
Notably, around 30% of solid organ transplant recipients experience post-transplant diabetes[1]
